5.1.6 Clindamycin - South & West

All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.

Switch to N&E website

Formulary

Back

5.1 Antibacterial drugs Toggle Pages

5.1.1 Penicillins 5.1.2 Cephalosporins, carbapenems, and other beta-lactams 5.1.3 Tetracyclines 5.1.4 Aminoglycosides 5.1.5 Macrolides 5.1.6 Clindamycin 5.1.7 Some other antibacterials 5.1.8 Sulfonamides and trimethoprim 5.1.9 Antituberculosis drugs 5.1.10 Antileprotic drugs 5.1.11 Nitroimidazole derivatives 5.1.12 Quinolones 5.1.13 Urinary-tract infections

Chapter 5: Infections Toggle Parent Pages

Principles of antibacterial treatment Upper respiratory tract infections Lower respiratory tract infections Acute exacerbation of bronchiectasis (non-cystic fibrosis) Urinary tract infections (UTI) Gastro-intestinal tract infections Genital tract infections Skin and soft tissue infections Eye infections Oral and dental infections Lyme disease guidance Meningitis guidance Methicillin Resistant Staphylococcus Aureus (MRSA) guidance COVID-19 treatments for patients who do not require hospitalisation 5.1 Antibacterial drugs 5.2 Antifungal drugs 5.3 Antiviral drugs 5.4 Antiprotozoal drugs 5.5 Anthelmintics

Print this page

Contact us about this page

5.1.6 Clindamycin

First Line

Second Line

Specialist

Hospital Only

Clindamycin

Capsules 150mg (£2.15 = 24 capsules)
Topical solution 1% in an aqueous alcoholic basis
Topical lotion 1% in an aqueous basis (£5.08 = 30ml)
Solution for injection 300mg/2ml, 600mg/4ml
Oral suspension 75mg/5ml (unlicensed preparation)

Indications

Cellulitis
Hidradenitis suppurativa - topical treatment
Folliculitis decalvans - topical treatment